pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: recall×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06566547: GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma

    Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04927949: Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

    Sponsor: University Hospital, Caen. Phase: PHASE4. Conditions: ST-elevation Myocardial Infarction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07540338: A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

    Sponsor: Alzamend Neuro, Inc.. Phase: PHASE1. Conditions: Bipolar I Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07534358: Intensive Case Management Between VA and Community Care for Suicide Prevention

    Sponsor: VA Eastern Colorado Health Care System. Phase: NA. Conditions: Suicidal Ideation, Mental Health Issue, Social Determinants of Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07621458: Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

    Sponsor: Seoul National University Hospital. Phase: . Conditions: Primary Aldosteronism

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06884748: Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

    Sponsor: Medical College of Wisconsin. Phase: EARLY_PHASE1. Conditions: Clostridioides Difficile Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07610148: A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451548: RCT on Running Water Sound During Urodynamic

    Sponsor: Princess Margaret Hospital, Hong Kong. Phase: NA. Conditions: Lower Urinary Tract Symptoms (LUTS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06547255: Exparel Versus Bupivacaine in Post-operative Pain Control

    Sponsor: Case Western Reserve University. Phase: PHASE4. Conditions: Liposomal Bupivacaine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05849155: Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

    Sponsor: St. Jude Children's Research Hospital. Phase: . Conditions: Genetic Predisposition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07586826: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

    Sponsor: Peking University People's Hospital. Phase: PHASE2. Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07572526: tDCS: Sleep to Mood in Depression (S2M-D)

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Major Depressive Disorder, MDD, Depression, Major Depressive Episode

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04358926: Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: COVID-19, Desaturation of Blood

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06724926: Concurrent Azeliragon With Craniospinal Irradiation

    Sponsor: NYU Langone Health. Phase: PHASE1. Conditions: Solid Tumor, High-grade Glioma, Leptomeningeal Metastasis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06197178: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

    Sponsor: Peking University. Phase: PHASE1. Conditions: Advanced Gastrointestinal Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07623278: Bacterial Profile Changes During Different Sodium Hypochlorite Irrigation Regimens and Calcium Hydroxide Medicament in Root Canal Treatment

    Sponsor: Hasanuddin University. Phase: NA. Conditions: Chronic Apical Abscess, Root Canal Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial

    Sponsor: Rohit Aggarwal, MD. Phase: PHASE4. Conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06120855: Study on Regulated Cannabis Sales in Pharmacies

    Sponsor: University of Bern. Phase: NA. Conditions: Marijuana Smoking, Cannabis, Cannabis Use

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04276155: Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

    Sponsor: Centre Hospitalier de PAU. Phase: PHASE4. Conditions: Atrial Fibrillation, Myocardial Infarction

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT05535426: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04362826: Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

    Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07537985: Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

    Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Hepatocellulcar Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442643: Epinephrine-Added Irrigation Versus Intravenous Tranexamic Acid in Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial

    Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Rotator Cuff Tear

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02696343: Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants

    Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Infant, Extremely Low Birth Weight, Feeding Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07402915: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07181915: Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits

    Sponsor: University of Leeds. Phase: NA. Conditions: COPD (Chronic Obstructive Pulmonary Disease)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07122011: Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction

    Sponsor: University of Gran Rosario. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03372811: Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)

    Sponsor: Psoriasis Research Institute of Guangzhou. Phase: PHASE2. Conditions: Psoriasis Vulgaris, Topical Administration

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05490771: Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07596771: Effects of AI-Generated Animated Videos on Dental Anxiety in Children

    Sponsor: Alanya Alaaddin Keykubat University. Phase: NA. Conditions: Pediatric Dental Anxiety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07426744: Antipyretic Therapy With and Without Cold Sponging

    Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Fever

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03915444: Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

    Sponsor: HonorHealth Research Institute. Phase: PHASE2. Conditions: Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06259734: Transfusion Camp for Medical Students in Rwanda

    Sponsor: University of British Columbia. Phase: NA. Conditions: Global Health, Medical Education

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07518264: Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder

    Sponsor: Beijing HuiLongGuan Hospital. Phase: NA. Conditions: Obsessive - Compulsive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06580509: TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: EARLY_PHASE1. Conditions: Hemorrhage, Surgical, Tonsillar Bleeding

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07503509: Physiological Study of High PEEP in Noninvasive Ventilation

    Sponsor: Chongqing Medical University. Phase: NA. Conditions: Respiratory Failure With Hypoxia

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT04222309: Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

    Sponsor: Northwell Health. Phase: PHASE1. Conditions: Glioma, Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, GBM, Brain Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05752799: Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids

    Sponsor: G.Gennimatas General Hospital. Phase: NA. Conditions: Opioid Use, Unspecified, Bariatric Surgery Candidate

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05883332: A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters

    Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Lower Urinary Tract Symptoms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06704932: A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee

    Sponsor: Sanofi. Phase: PHASE1. Conditions: Osteoarthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05410132: Internet-based Mindfulness-based Training (iMBT) for People With Depression

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Mindfulness, Depression

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05792332: Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

    Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta. Phase: NA. Conditions: Atypical Parkinsonism, MSA - Multiple System Atrophy, PSP, Nurse-Patient Relations, Nurse Physician Relations

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05724498: Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Insomnia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07391098: Peripheral Perfusion and Outcomes in ICU Patients With Sepsis

    Sponsor: Alexandra Elena Lazăr. Phase: . Conditions: SEPSIS, Septic Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07064798: Cryocompression for CIPN

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Chemotherapy-induced Peripheral Neuropathy, Taxane-Induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02942290: A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Myelodysplastic Syndromes (MDS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06864013: SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE2. Conditions: Locally Advanced Rectal Cancer (LARC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07395960: The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment

    Sponsor: Fudan University. Phase: PHASE1. Conditions: Mild Cognitive Impairment, Overweight or Obesity, Elderly

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05675982: Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

    Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06556082: Effect of PNF-Based Upper Extremity Strengthening With Core Stabilization on Fitness in Amputee Football Players

    Sponsor: Uskudar University. Phase: NA. Conditions: Amputation, Lower Limb Amputation

    full page →ctgov ↗
    ← prev
    page 51 of 104
    next →